Mersin University
Mersin, 33140, Turkey (Türkiye)
Location status: Recruiting
Location contact
Aysun Katmerlikaya, MSc
CONTACT
Öznur Tunca, Prof. Dr.
CONTACT
NCT Number: NCT06949696
The purpose of this study is to examine the effects of dual-task training and cognitive rehabilitation on gait, balance, fatigue and cognitive performance in individuals with multiple sclerosis.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Mersin, 33140, Turkey (Türkiye)
Location status: Recruiting
Aysun Katmerlikaya, MSc
CONTACT
Öznur Tunca, Prof. Dr.
CONTACT
Multiple sclerosis (MS) is a complex disease characterized by chronic, inflammatory, demyelinating and neurodegenerative processes of the central nervous system (CNS) with heterogeneous clinical symptoms. Balance, gait and cognitive impairment are among the biggest problems in individuals with MS and significantly affect their daily lives.
Dual Task (DT); is the process of performing two tasks that can be performed independently and have different purposes simultaneously. Walking with dual tasks has recently been shown to resemble typical walking performance in daily life, thus providing clinicians with a realistic walking performance measurement in daily life. Although the effects of dual task performance in various neurological diseases have been partially described in the literature, the comparison of dual task training and cognitive rehabilitation on walking, balance, fatigue and cognitive performance has not been made and due to this deficiency in the literature, our study was planned and has originality. The aim of our study is to investigate the effects of dual task training and cognitive rehabilitation on walking, balance, fatigue and cognitive performance in individuals with MS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In dual task training, patients will be given cognitive exercises such as counting backwards from 100 by 3, counting the names of cities, girls and boys while walking.
In cognitive rehabilitation, patients will be given paper-and-pencil activities and exercises to find the difference between two pictures.
In conventionel physiotherapy, patients will be given posture exercises for balance and strengthening.
Time frame: a year
DGI is a test that measures the capacity to adapt to changes in walking.It evaluates a total of 8 parameters over 24 points. Values of 19 points and below define the presence of a fall risk.
Time frame: a year
Timed 25 Food Walk Test is a test that evaluates walking speed. In the test, the patient is asked to walk 25 steps as quickly and safely as possible and the time is recorded in seconds with the average of 2 trials.
Time frame: a year
The 12-item MS Walking Scale (12-MSWS) that evaluates walking ability over the last 2 weeks, scaled from 0 to 100.
Time frame: a year
BICAMS (Brief International Cognitive Assessment for MS) is an international initiative to recommend and support a cognitive assessment that is brief, practical and universal.
Time frame: a year
Trial Making Test (TMT)is used to evaluate individuals' executive functions, visual-motor perception, visual scanning and attention speed, motor function, organization, and planning.
Time frame: a year
It is a multidimensional self-report questionnaire consisting of 21 questions in total, which is frequently used in individuals with MS and evaluates subjective fatigue physically (9 items), cognitively (10 items) and psychosocially (2 items).
Contact information is provided by the study sponsor or research team.
Toros University
Other
Effects of Dual-Task Training and Cognitive Rehabilitation on Gait, Balance, Fatigue and Cognitive Performance in Individuals With Multiple Sclerosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736482
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Afyonkarahisar, Merkez, Turkey (Türkiye)
View Trial DetailsNCT07630311
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ioannina, Greece
View Trial DetailsNCT06170970
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Baltimore, Maryland, United States
View Trial DetailsNCT05357781
Agammaglobulinemia, Autoimmune Diseases
Bern, Canton of Bern, Switzerland
View Trial Details